Log In
Print
BCIQ
Print
Print this Print this
 

RTS,S vaccine (Mosquirix) (GSK257049)

Also known as: Malaria vaccine

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionMalaria vaccine targeting the circumsporozoite protein (CSP) sequence of Plasmodium falciparum combined with the AS01 adjuvant
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationMalaria
Indication DetailsPrevent malaria infection in infants and children; Vaccinate against malaria
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today